Chronic wounds cause several discomforts in patients and require huge expenses in terms of time and resources. Estimates indicate that the global market will increase from USD 12.36 billion in 2022 to USD 19.52 billion by 2029. The consequences related to chronic and non-healing wounds are pathological inflammation, impaired angiogenesis, difficult in re-epithelization and formation of drug resistant biofilms. These types of wounds are a global health issue, statistically affecting the 1-2% of the population in developed countries during their lives. Moreover, antimicrobial resistance (AMR) is a correlated issue: this happens when pathogens no longer respond to antimicrobial agents, drugs becomes ineffective and severe infections become threatening.